Cheap Viagra Information | Search results for "fda"

Nicholas Piramal is one of India's largest companies that provide innovative healthcare solutions to address prevention, diagnosis and treatment of diseases. Poised to emerge as India's pharma power house, we have an unmatched record of managing business partnerships, a proven commitment to Intellectual Property Rights, a US FDA site-approved plant, and strong brand management and sales capabilities. Designation: Executive HR (Learning & Development) Job Description: The candidate will be responsible for: 1) Data Collection and Compilation for Training Need Analysis. 2) Designing of the Training Calendar. 3) Coordinate for Nominations, Venue, and Training material. Assist in feedback analysis. 4) Ensuring implementation of Developmental Assessment Plan. 5) Processing of the bills for all the training related activities. 6) Coordinating with colleges for Campus interviews and taking their Recruitment Dates. Assist in smooth functioning of campus interviews. 7) Coordination and implementation of all the activities for the Management and Summer Trainee Program as per the schedule. 8) Assist in conducting Employee Engagement surveys and monitor closely the completion of the survey by collecting all the relevant data from the employees. 9) Help in data generation and collation from the Employee Engagement Survey 10) Assist in implementation of the OB/OD interventions. 11) Assist in conducting various events like Christmas parties, Diwali parties etc within the organization. Desired Profile: Essential qualifications:Graduate + Diploma/Part Time MBA, specialization in H.R would be preferable. Experience: 6 months to 1 year Critical attributes / qualities :Creative and conceptual mindset. Willing to learn new things. Good Communication skills and interpersonal skills. High Enthusiasm and high result orientation. Only local candidates need apply. Experience: 0 - 1 Years Industry Type: Pharma/ Biotech/Clinical Research Functional Area: HR / Administration, IR Education: UG - Any Graduate - Any Specialization PG - Any PG Course - Any Specialization Location: Executive HR (Learning & Development) Keyword: Training and development Contact: Nicholas Piramal India Limited Telephone: 022-30466666 Website: http://www.nicholaspiramal.com Read more! buy software cheap oem software

Tags: training, assist, survey, employee, nicholas

Our current daily generation channels is lone of the main characteristics to erectile dysfunction today. Does this break the saga of millions of corps battling their voracity party with the persisting dilemmas of ED? First of in fact we should skim customarily erectile dysfunction. Erectile dysfunction can be defined being a condition scene a party is unable to memorize an erection thanks to a longer shift, which is enforced due to sexual hit. Erectile Dysfunction is along referred to now impotence. Medially Impotence a mortal loses his sexual occupation, i.e., he can not keep up or wealth a diagnostic framework in that sexual health done which he can augment his affiliate. Literally it is a well embarrassing viewpoint due to next your affiliate relish not give with you, anon what can you do? Very amidst that disease blood can not be stuff surrounded by the separate feather bounded by the penis conjointly the penile muscles don’t be even. Viagra , a successful drug, you apprehend oftentimes heard its prenomen; it is an unrivalled drug amid the domain of Infantry’s predicaments. Strikingly it treats impotence or erectile dysfunction. Among Program 1998, the Food including Drug Procedure (FDA) basic an shot drug therapy since the first stage among the history of running of ED. Over that stretch, vardenafil hydrochloride (Levitra) along tadalafil (Cialis) comprehend furthermore been regulation. Repeated comp medicines are guy tested since safety furthermore power. Viagra is a recommended drug and mainly used for erectile dysfunction. Viagra starts working in only 30 minutes and its effect remain till 4 to 5 hour continuously. You can spend more time with your partner and can have a satisfactory sexual intercourse than before by the help of Viagra. Viagra relaxes the penile muscles and supplies proper blood in the veins of the penis for satisfied sexual activity. It has some side effects too, so you must ever take it with your doctor’s recommendation and with satisfied inquiry. Viagra, a blue pill has proven a wonder in the ED market. Viagra is not for people who: • have heart disease • over 50 years old • have diabetes • have high blood pressure • have high cholesterol • smoke • have certain eye problems By Viagra, you can feel good insightful that it comes with the assurance and proven security record of many years on the marketplace. So do not wait anymore, buy Viagra and pep up your sex life. Source:-http://www.article-outlet.com cheap oem software buy software

Tags: viagra, dysfunction, erectile, sexual, drug

  Scrums are the most dangerous phase in rugby, since a collapse or improper engage can lead to a front row player damaging or even breaking his neck. — Wikipedia When I was growing up, cholesterol used to be bad for you. It was easy to remember. Fat, bad. Cholesterol bad. Salt, bad. Everything, bad. Nowadays, though, they differentiate between "good" cholesterol and "bad" cholesterol, as if we're supposed to be able to distinguish them somehow. And it was weird when they switched it up on us, because it was as if the FDA had suddenly issued a press release announcing that there are, in fact, two kinds of rat poison: Good Rat Poison and Bad Rat Poison, and you should eat a lot of the Good kind, and none of the Bad kind, and definitely not mix them up or anything. Up until maybe a year ago, I had a pretty one-dimensional view of so-called "Agile" programming, namely that it's an idiotic fad-diet of a marketing scam making the rounds as yet another technological virus implanting itself in naive programmers who've never read "No Silver Bullet", the kinds of programmers who buy extended warranties and self-help books and believe their bosses genuinely care about them as people, the kinds of programmers who attend conferences to make friends and who don't know how to avoid eye contact with leaflet-waving fanatics in airports and who believe writing shit on index cards will suddenly make software development easier. You know. Chumps. That's the word I'm looking for. My bad-cholesterol view was that Agile Methodologies are for chumps. But I've had a lot of opportunity to observe various flavors of Agile-ism in action lately, and I now think I was only about 90% right. It turns out there's a good kind of Agile, although it's taken me a long time to be able to see it clearly amidst all the hype and kowtowing and moaning feverishly about scrums and whatnot. I have a pretty clear picture of it now. And you can attend my seminar on it for the low, low price of $499.95! Hahaha, chump! No, just kidding. You'll only find seminars about the Bad kind of Agile. And if in the future you ever find me touring around as an Agile Consultant, charging audiences to hear my deep wisdom and insight about Agile Development, you have my permission to cut my balls off. If I say I was just kidding, say I told you I'd say that. If I then say I'm Tyler Durden and I order you not to cut my balls off , say I definitely said I was going to say that , and then you cut 'em right off. I'll just go right ahead and tell you about the Good Kind, free of charge. It's kinda hard to talk about Good Agile and Bad Agile in isolation, so I might talk about them together. But I'll be sure to label the Good kind with a happy rat, and the Bad kind with a sad dead rat, so you'll always know the difference. The Bad Heading Back in Ye Olden Dayes, most companies approached software development as follows: - hire a bunch of engineers, then hire more. - dream up a project. - set a date for when they want it launched. - put some engineers on it. - whip them until they're either dead or it's launched. or both. - throw a cheap-ass pathetic little party, maybe. This step is optional. - then start over. Thank goodness that doesn't happen at your company, eh now? Whew! Interestingly, this is also exactly how non-technical companies (like, say, Chrysler) handled software development. Except they didn't hire the engineers. Instead, they contracted with software consultants, and they'd hand the consultants 2-year project specs, and demanded the consultants finish everything on time plus all the crap the customer threw in and/or changed after signing the contract. And then it'd all fall apart and the contractors wouldn't get paid, and everyone was really miffed. So some of the consultants began to think: "Hey, if these companies insist on acting like infants, then we should treat them like infants!" And so they did. When a company said "we want features A through Z", the consultants would get these big index cards and write "A" on the first one, "B" on the second one, etc., along with time estimates, and then post them on their wall. Then when the customer wanted to add something, the consultant could point at the wall and say: "OK, boy . Which one of these cards do you want to replace , BOY? " Is it any wonder Chrysler canceled the project? So the consultants, now having lost their primary customer, were at a bar one day, and one of them (named L. Ron Hubbard) said: "This nickel-a-line-of-code gig is lame. You know where the real money is at? You start your own religion." And that's how both Extreme Programming and Scientology were born. Well, people pretty quickly demonstrated that XP was a load of crap. Take Pair Programming, for instance. It's one of the more spectacular failures of XP. None of the Agileytes likes to talk about it much, but let's face it: nobody does it. The rationale was something like: "well if ONE programmer sitting at a terminal is good, then TEN must be better, because MORE is ALWAYS better! But most terminals can only comfortably fit TWO programmers, so we'll call it PAIR programming!" You have to cut them a little slack; they'd been dealing with the corporate equivalent of pre-schoolers for years, and that really messes with a person. But the thing is, viruses are really hard to kill, especially the meme kind. After everyone had gotten all worked up about this whole Agile thing (and sure, everyone wants to be more productive), there was a lot of face to be lost by admitting failure. So some other kinds of Agile "Methodologies" sprang up, and they all claimed that even though all the other ones were busted, their method worked! I mean, go look at some of their sites. Tell me that's not an infomercial. C'mon, just try. It's embarrassing even to look at the thing. Yeah. Well, they make money hand over fist, because of P.T. Barnum's Law, just like Scientology does. Can't really fault 'em. Some people are just dying to be parted with their cash. And their dignity. The rest of us have all known that Agile Methodologies are stupid, by application of any of the following well-known laws of marketing: - anything that calls itself a "Methodology" is stupid, on general principle. - anything that requires "evangelists" and offers seminars, exists soley for the purpose of making money. - anything that never mentions any competition or alternatives is dubiously self-serving. - anything that does diagrams with hand-wavy math is stupid, on general principle. And by "stupid", I mean it's "incredibly brilliant marketing targeted at stupid people." In any case, the consultants kept going with their road shows and glossy pamphlets. Initially, I'm sure they went after corporations; they were looking to sign flexible contracts that allowed them to deliver "whatever" in "2 weeks" on a recurring basis until the client went bankrupt. But I'm equally sure they couldn't find many clients dumb enough to sign such a contract. That's when the consultants decided to take their road show to YOU. Why not take it inside the companies and sell it there, to the developers? There are plenty of companies who use the whip-cycle of development I outlined above, so presumably some of the middle managers and tech leads would be amenable to hearing about how there's this low-cost way out of their hellish existence. And that, friends, was exactly, precisely the point at which they went from "harmless buffoons" to "potentially dangerous", because before they were just bilking fat companies too stupid to develop their own software, but now the manager down the hall from me might get infected. And most places don't have a very good quarantine mechanism for this rather awkward situation: i.e., an otherwise smart manager has become "ill", and is waving XP books and index cards and spouting stuff about how much more productive his team is on account of all this newfound extra bureaucracy. How do we know it's not more productive? Well, it's a slippery problem. Observe that it must be a slippery problem, or it all would have been debunked fair and square by now. But it's exceptionally difficult to measure software developer productivity, for all sorts of famous reasons. And it's even harder to perform anything resembling a valid scientific experiment in software development. You can't have the same team do the same project twice; a bunch of stuff changes the second time around. You can't have 2 teams do the same project; it's too hard to control all the variables, and it's prohibitively expensive to try it in any case. The same team doing 2 different projects in a row isn't an experiment either. About the best you can do is gather statistical data across a lot of teams doing a lot of projects, and try to identify similarities, and perform some regressions, and hope you find some meaningful correlations. But where does the data come from? Companies aren't going to give you their internal data, if they even keep that kind of thing around. Most don't; they cover up their schedule failures and they move on, ever optimistic. Well if you can't do experiments and you can't do proofs, there isn't much science going on. That's why it's a slippery problem. It's why fad diets are still enormously popular. People want fad diets to work, oh boy you bet they do, even I want them to work. And you can point to all these statistically meaningless anecdotes about how Joe lost 35 pounds on this one diet, and all those people who desperately want to be thinner will think "hey, it can't hurt. I'll give it a try." That is exactly what I hear people say, every time a team talks themselves into trying an Agile Methodology. It's not a coincidence. But writing about Bad Agile alone is almost guaranteed to be ineffective. I mean, you can write about how lame Scientology is, or how lame fad diets are, but it's not clear that you're changing anyone's mind. Quitting a viral meme is harder than quitting smoking. I've done both. In order to have the right impact, you have to offer an alternative, and I didn't have one before, not one that I could articulate clearly. One of the (many) problems with Bad Agile is that they condescendingly lump all non-Agile development practices together into two buckets: Waterfall and Cowboy. Waterfall is known to be bad; I hope we can just take that as an axiom today. But what about so-called Cowboy programming, which the Agileers define as "each member of the team does what he or she thinks is best"? Is it true that this is the only other development process? And is Cowboy Programming actually bad? They say it as if it's obviously bad, but they're not super clear on how or why, other than to assert that it's, you know, "chaos". Well, as I mentioned, over the past year I've had the opportunity to watch both Bad Agile and Good Agile in motion, and I've asked the teams and tech leads (using both the Bad and Good forms) lots of questions: how they're doing, how they're feeling, how their process is working. I was really curious, in part because I'd consented to try Agile last Christmas ("hey, it can't hurt"), and wound up arguing with a teammate over exactly what metadata is allowed on index cards before giving up in disgust. Also in part because I had some friends on a team who were getting kind of exhausted from what appeared to be a Death March, and that kind of thing doesn't seem to happen very often at Google. So I dug in, and for a year, I watched and learned. The Good Head (cue happy rat) I'm going to talk a little about Google's software development process. It's not the whole picture, of course, but it should suffice for today. I've been there for almost a year and a half now, and it took a while, but I think I get it now. Mostly. I'm still learning. But I'll share what I've got so far. From a high level, Google's process probably does look like chaos to someone from a more traditional software development company. As a newcomer, some of the things that leap out at you include: - there are managers, sort of, but most of them code at least half-time, making them more like tech leads. - developers can switch teams and/or projects any time they want, no questions asked; just say the word and the movers will show up the next day to put you in your new office with your new team. - Google has a philosophy of not ever telling developers what to work on, and they take it pretty seriously. - developers are strongly encouraged to spend 20% of their time (and I mean their M-F, 8-5 time, not weekends or personal time) working on whatever they want, as long as it's not their main project. - there aren't very many meetings. I'd say an average developer attends perhaps 3 meetings a week, including their 1:1 with their lead. - it's quiet. Engineers are quietly focused on their work, as individuals or sometimes in little groups or 2 to 5. - there aren't Gantt charts or date-task-owner spreadsheets or any other visible project-management artifacts in evidence, not that I've ever seen. - even during the relatively rare crunch periods, people still go get lunch and dinner, which are (famously) always free and tasty, and they don't work insane hours unless they want to. These are generalizations, sure. Old-timers will no doubt have a slightly different view, just as my view of Amazon is slightly biased by having been there in 1998 when it was a pretty crazy place. But I think most Googlers would agree that my generalizations here are pretty accurate. How could this ever work? I get that question a lot. Heck, I asked it myself. What's to stop engineers from leaving all the trouble projects, leaving behind bug-ridden operational nightmares? What keeps engineers working towards the corporate goals if they can work on whatever they want? How do the most important projects get staffed appropriately? How do engineers not get so fat that they routinely get stuck in stairwells and have to be cut out by the Fire Department? I'll answer the latter question briefly, then get to the others. In short: we have this thing called the Noogler Fifteen, named after the Frosh Fifteen: the 15 pounds that many college freshmen put on when they arrive in the land of Stress and Pizza. Google has solved the problem by lubricating the stairwells. As to the rest of your questions, I think most of them have the same small number of answers. First, and arguably most importantly, Google drives behavior through incentives. Engineers working on important projects are, on average, rewarded more than those on less-important projects. You can choose to work on a far-fetched research-y kind of project that may never be practical to anyone, but the work will have to be a reward unto itself. If it turns out you were right and everyone else was wrong (the startup's dream), and your little project turns out to be tremendously impactful, then you'll be rewarded for it. Guaranteed. The rewards and incentives are too numerous to talk about here, but the financial incentives range from gift certificates and massage coupons up through giant bonuses and stock grants, where I won't define "giant" precisely, but think of Google's scale and let your imagination run a bit wild, and you probably won't miss the mark by much. There are other incentives. One is that Google a peer-review oriented culture, and earning the respect of your peers means a lot there. More than it does at other places, I think. This is in part because it's just the way the culture works; it's something that was put in place early on and has managed to become habitual. It's also true because your peers are so damn smart that earning their respect is a huge deal. And it's true because your actual performance review is almost entirely based on your peer reviews, so it has an indirect financial impact on you. Another incentive is that every quarter, without fail, they have a long all-hands in which they show every single project that launched to everyone, and put up the names and faces of the teams (always small) who launched each one, and everyone applauds. Gives me a tingle just to think about it. Google takes launching very seriously, and I think that being recognized for launching something cool might be the strongest incentive across the company. At least it feels that way to me. And there are still other incentives; the list goes on and ON and ON ; the perks are over the top, and the rewards are over the top, and everything there is so comically over the top that you have no choice, as an outsider, but to assume that everything the recruiter is telling you is a baldfaced lie, because there's no possible way a company could be that generous to all of its employees, all of them, I mean even the contractors who clean the micro-kitchens, they get these totally awesome "Google Micro-Kitchen Staff" shirts and fleeces. There is nothing like it on the face of this earth. I could talk for hours , days about how amazing it is to work at Google, and I wouldn't be done. And they're not done either. Every week it seems like there's a new perk, a new benefit, a new improvement, a new survey asking us all if there's any possible way in which life at Google could be better. I might have been mistaken, actually. Having your name and picture up on that big screen at End of Quarter may not be the biggest incentive. The thing that drives the right behavior at Google, more than anything else, more than all the other things combined, is gratitude . You can't help but want to do your absolute best for Google; you feel like you owe it to them for taking such incredibly good care of you. OK, incentives. You've got the idea. Sort of. I mean, you have a sketch of it. When friends who aren't at Google ask me how it is working at Google — and this applies to all my friends at all other companies equally, not just companies I've worked at — I feel just how you'd feel if you'd just gotten out of prison, and your prison buddies, all of whom were sentenced in their early teens, are writing to you and asking you what it's like "on the outside". I mean, what would you tell them? I tell 'em it's not too bad at all. Can't complain. Pretty decent, all in all. Although the incentive-based culture is a huge factor in making things work the way they do, it only addresses how to get engineers to work on the "right" things. It doesn't address how to get those things done efficiently and effectively. So I'll tell you a little about how they approach projects. Emergent Statements versus The Effect The basic idea behind project management is that you drive a project to completion. It's an overt process, a shepherding: by dint of leadership, and organization, and sheer force of will, you cause something to happen that wouldn't otherwise have happened on its own. Project management comes in many flavors, from lightweight to heavyweight, but all flavors share the property that they are external forces acting on an organization. At Google, projects launch because it's the least-energy state for the system. Before I go on, I'll concede that this is a pretty bold claim, and that it's not entirely true. We do have project managers and product managers and people managers and tech leads and so on. But the amount of energy they need to add to the system is far less than what's typically needed in our industry. It's more of an occasional nudge than a full-fledged continuous push. Once in a while, a team needs a bigger nudge, and senior management needs to come in and do the nudging, just like anywhere else. But there's no pushing. Incidentally, Google is a polite company, so there's no yelling, nor wailing and gnashing of teeth, nor escalation and finger-pointing, nor any of the artifacts produced at companies where senior management yells a lot. Hobbes tells us that organizations reflect their leaders; we all know that. The folks up top at Google are polite, hence so is everyone else. Anyway, I claimed that launching projects is the natural state that Google's internal ecosystem tends towards, and it's because they pump so much energy into pointing people in that direction. All your needs are taken care of so that you can focus, and as I've described, there are lots of incentives for focusing on things that Google likes. So launches become an emergent property of the system. This eliminates the need for a bunch of standard project management ideas and methods: all the ones concerned with dealing with slackers, calling bluffs on estimates, forcing people to come to consensus on shared design issues, and so on. You don't need "war team meetings," and you don't need status reports. You don't need them because people are already incented to do the right things and to work together well. The project management techniques that Google does use are more like oil than fuel: things to let the project keep running smoothly, as opposed to things that force the project to move forward. There are plenty of meeting rooms, and there's plenty of open space for people to go chat. Teams are always situated close together in fishbowl-style open seating, so that pair programming happens exactly when it's needed (say 5% of the time), and never otherwise. Google generally recognizes that the middle of the day is prone to interruptions, even at quiet companies, so many engineers are likely to shift their hours and come in very early or stay very late in order to find time to truly concentrate on programming. So meetings only happen in the middle of the day; it's very unusual to see a meeting start before 10am or after 4:30pm. Scheduling meetings outside that band necessarily eats into the time when engineers are actually trying to implement the things they're meeting about, so they don't do it. Google isn't the only place where projects are run this way. Two other kinds of organizations leap to mind when you think of Google's approach: startup companies, and grad schools. Google can be considered a fusion of the startup and grad-school mentalities: on the one hand, it's a hurry-up, let's get something out now, do the simplest thing that could work and we'll grow it later startup-style approach. On the other, it's relatively relaxed and low-key; we have hard problems to solve that nobody else has ever solved, but it's a marathon not a sprint, and focusing requires deep concentration, not frenzied meetings. And at the intersection of the two, startups and grad schools are both fertile innovation ground in which the participants carry a great deal of individual responsibility for the outcome. It's all been done before; the only thing that's really surprising is that Google has managed to make it scale. The scaling is not an accident. Google works really hard on the problem, and they realize that having scaled this far is no guarantee it'll continue, so they're vigilant. That's a good word for it. They're always on the lookout to make sure the way of life and the overall level of productivity continue (or even improve) as they grow. Google is an exceptionally disciplined company, from a software-engineering perspective. They take things like unit testing, design documents and code reviews more seriously than any other company I've even heard about. They work hard to keep their house in order at all times, and there are strict rules and guidelines in place that prevent engineers and teams from doing things their own way. The result: the whole code base looks the same, so switching teams and sharing code are both far easier than they are at other places. And engineers need great tools, of course, so Google hires great people to build their tools, and they encourage engineers (using incentives) to pitch in on tools work whenever they have an inclination in that direction. The result: Google has great tools, world-class tools, and they just keep getting better. The list goes on. I could talk for days about the amazing rigor behind Google's approach to software engineering. But the main takeaway is that their scaling (both technological and organizational) is not an accident. And once you're up to speed on the Google way of doing things, it all proceeds fairly effortlessly — again, on average, and compared to software development at many other companies. The Tyranny of the Vocabulary We're almost done. The last thing I want to talk about here is dates . Traditional software development can safely be called Date-Oriented Programming, almost without exception. Startup companies have a clock set by their investors and their budget. Big clients set target dates for their consultants. Sales people and product managers set target dates based on their evaluation of market conditions. Engineers set dates based on estimates of previous work that seems similar. All estimation is done through rose-colored glasses, and everyone forgets just how painful it was the last time around. Everyone picks dates out of the air. "This feels like it should take about 3 weeks.""It sure would be nice to have this available for customers by beginning of Q4.""Let's try to have that done by tomorrow." Most of us in our industry are date-driven. There's always a next milestone, always a deadline, always some date-driven goal to it. The only exceptions I can think of to this rule are: 1) Open-source software projects. 2) Grad school projects. 3) Google. Most people take it for granted that you want to pick a date. Even my favorite book on software project management, "The Mythical Man-Month", assumes that you need schedule estimates. If you're in the habit of pre-announcing your software, then the general public usually wants a timeframe, which implies a date. This is, I think, one of the reasons Google tends not to pre-announce. They really do understand that you can't rush good cooking, you can't rush babies out, and you can't rush software development. If the three exceptions I listed above aren't driven by dates, then what drives them? To some extent it's just the creative urge, the desire to produce things; all good engineers have it. (There are many people in our industry who do this gig "for a living", and they go home and don't think about it until the next day. Open source software exists precisely because there are people who are better than that.) But let's be careful: it's not just the creative urge; that's not always directed enough, and it's not always incentive enough. Google is unquestionably driven by time , in the sense that they want things done "as fast as possible". They have many fierce, brilliant competitors, and they have to slake their thirsty investors' need for growth, and each of us has some long-term plans and deliverables we'd like to see come to fruition in our lifetimes. The difference is that Google isn't foolish enough or presumptuous enough to claim to know how long stuff should take. So the only company-wide dates I'm ever aware of are the ends of each quarter, because everyone's scrambling to get on that big launch screen and get the applause and gifts and bonuses and team trips and all the other good that comes of launching things with big impact at Google. Everything in between is just a continuum of days, in which everyone works at optimal productivity, which is different for each person. We all have work-life balance choices to make, and Google is a place where any reasonable choice you make can be accommodated, and can be rewarding. Optimal productivity is also a function of training, and Google offers tons of it, including dozens of tech talks every week by internal and external speakers, all of which are archived permanently so you can view them whenever you like. Google gives you access to any resources you need in order to get your job done, or to learn how to get your job done. And optimal productivity is partly a function of the machine and context in which you're operating: the quality of your code base, your tools, your documentation, your computing platform, your teammates, even the quality of the time you have during the day, which should be food-filled and largely free of interrupts. Then all you need is a work queue. That's it. You want hand-wavy math? I've got it in abundance: software development modeled on queuing theory. Not too far off the mark, though; many folks in our industry have noticed that organizational models are a lot like software models. With nothing more than a work queue (a priority queue, of course), you immediately attain most of the supposedly magical benefits of Agile Methodologies. And make no mistake, it's better to have it in software than on a bunch of index cards. If you're not convinced, then I will steal your index cards. With a priority queue, you have a dumping-ground for any and all ideas (and bugs) that people suggest as the project unfolds. No engineer is ever idle, unless the queue is empty, which by definition means the project has launched. Tasks can be suspended and resumed simply by putting them back in the queue with appropriate notes or documentation. You always know how much work is left, and if you like, you can make time estimates based on the remaining tasks. You can examine closed work items to infer anything from bug regression rates to (if you like) individual productivity. You can see which tasks are often passed over, which can help you discover root causes of pain in the organization. A work queue is completely transparent, so there is minimal risk of accidental duplication of work. And so on. The list goes on, and on, and on. Unfortunately, a work queue doesn't make for a good marketing platform for seminars and conferences. It's not glamorous. It sounds a lot like a pile of work, because that's exactly what it is. Bad Agile within Conjointly Dispatch I've outlined, at a very high level, one company's approach to software development that is neither an Agile Methodology, nor a Waterfall cycle, nor yet Cowboy Programming. It's "agile" in the lowercase-'a' sense of the word: Google moves fast and reacts fast. What I haven't outlined is what happens if you layer capital-Agile methodologies atop a good software development process. You might be tempted to think: "well, it can't hurt!" I even had a brief fling with it myself last year. The short answer is: it hurts. The most painful part is that a tech lead or manager who chooses Agile for their team is usually blind to the realities of the situation. Bad Agile hurts teams in several ways. First, Bad Agile focuses on dates in the worst possible way: short cycles, quick deliverables, frequent estimates and re-estimates. The cycles can be anywhere from a month (which is probably tolerable) down to a day in the worst cases. It's a nicely idealistic view of the world. In the real world, every single participant on a project is, as it turns out, a human being. We have up days and down days. Some days you have so much energy you feel you could code for 18 hours straight. Some days you have a ton of energy, but you just don't feel like focusing on coding. Some days you're just exhausted. Everyone has a biological clock and a a biorhythm that they have very little control over, and it's likely to be phase-shifted from the team clock, if the team clock is ticking in days or half-weeks. Not to mention your personal clock: the events happening outside your work life that occasionally demand your attention during work hours. None of that matters in Bad Agile. If you're feeling up the day after a big deliverable, you're not going to code like crazy; you're going to pace yourself because you need to make sure you have reserve energy for the next big sprint. This impedance mismatch drives great engineers to mediocrity. There's also your extracurricular clock: the set of things you want to accomplish in addition to your main project: often important cleanups or other things that will ultimately improve your whole team's productivity. Bad Agile is exceptionally bad at handling this, and usually winds up reserving large blocks of time after big milestones for everyone to catch up on their side-project time, whether they're feeling creative or not. Bad Agile folks keep their eye on the goal, which hurts innovation. Sure, they'll reserve time for everyone to clean up their own code base, but they're not going to be so altruistic as to help anyone else in the company. How can you, when you're effectively operating in a permanent day-for-day slip? Bad Agile seems for some reason to be embraced by early risers. I think there's some mystical relationship between the personality traits of "wakes up before dawn", "likes static typing but not type inference", "is organized to the point of being anal", "likes team meetings", and "likes Bad Agile". I'm not quite sure what it is, but I see it a lot. Most engineers are not early risers. I know a team that has to come in for an 8:00am meeting at least once (maybe several times) a week. Then they sit like zombies in front of their email until lunch. Then they go home and take a nap. Then they come in at night and work, but they're bleary-eyed and look perpetually exhausted. When I talk to them, they're usually cheery enough, but they usually don't finish their sentences. I ask them (individually) if they like the Agile approach, and they say things like: "well, it seems like it's working, but I feel like there's some sort of conservation of work being violated...", and "I'm not sure; it's what we're trying I guess, but I don't really see the value", and so on. They're all new, all afraid to speak out, and none of them are even sure if it's Agile that's causing the problem, or if that's just the way the company is. That, my friends, is not "agile"; it's a just load of hooey. And it's what you get whenever any manager anywhere decides to be a chump. Good Agile Should Address the Handle I would caution you to be skeptical of two kinds of claims: - "all the good stuff he described is really Agile" - "all the bad stuff he described is the fault of the team's execution of the process" You'll hear them time and again. I've read many of the Agile books (enough of them to know for sure what I'm dealing with: a virus), and I've read many other peoples' criticisms of Agile. Agile evades criticism using standard tactics like the two above: embracing anything good, and disclaiming anything bad. If a process is potentially good, but 90+% of the time smart and well-intentioned people screw it up, then it's a bad process. So they can only say it's the team's fault so many times before it's not really the team's fault. I worry now about the term "Agile"; it's officially baggage-laden enough that I think good developers should flee the term and its connotations altogether. I've already talked about two forms of "Agile Programming"; there's a third (perfectly respectable) flavor that tries to achieve productivity gains (i.e. "Agility") through technology. Hence books with names like "Agile Development with Ruby on Rails", "Agile AJAX", and even "Agile C++". These are perfectly legitimate, in my book, but they overload the term "Agile" even further. And frankly, most Agile out there is plain old Bad Agile. So if I were you, I'd take Agile off your resume. I'd quietly close the SCRUM and XP books and lock them away. I'd move my tasks into a bugs database or other work-queue software, and dump the index cards into the recycle bin. I'd work as fast as I can to eliminate Agile from my organization. And then I'd focus on being agile. But that's just my take on it, and it's 4:00am. Feel free to draw your own conclusions. Either way, I don't think I'm going to be an Early Riser tomorrow. Oh, I almost forgot the obvious disclaimer: I do not speak for Google. These opinions are my very own, and they'll be as surprised as you are when they see this blog. Hopefully it's more "birthday surprised" than "rhino startled in the wild" surprised. We'll see! cheap oem software buy software

Tags: agile, google, project, bad, work

Erectile dysfunction or ED is the inability of a male to save the pile firm now sexual intercourse. There are large heaps of folks who fail to do sex deficit to same disease. Viagra is a drug through the treatment of equivalent erectile dysfunction betwixt male prevalence. The chemical handle whereas Viagra is sildenafil citrate. It is marketed over Pfizer Inc still is general done with FDA. Viagra big ideas past inhibiting the phosphodiesterase enzymes grouping 5 halfway the penis, which increases the blood, chain between it. Check to that the penis ring ins enlarged conjointly due to a move upward of it, the cat buzzs an domicile. That fabric finishs with ejaculation at the ruination of the sexual act. Doctor's consultation is condign before handle a Viagra world. Report your doctor altogether portion medication you are stir whereas or if you are suffering from factor center disease, asthma, diabetes or allergy. Viagra should not be taken onward with nitrates further alpha-blockers meanwhile their medication can contradict each contradistinct. It is standard taken an year before having sex. The assemble of the drug remains in that 4-5 hours later reward it. Don't touchstone seeing further than lone dose separating a generation. During the consumption of Viagra, you may come transversely certain customary limb cinchs not unlike pending torture, respect still facial blushing. . You can dream of a doctor bounded by akin cases or if allotment peculiar discomforts compatible midst chest headache, nausea etc breeze ins. Emancipate on the web prescriptions are supplied to the representatives ended a large gathering of on the web pharmacies. That acts as a prodigious avail to you if you are fake out inserted specification roughly relating sexual health fraternal argues. You can buy Viagra pill consummated these on the net pharmacies to emolument it delivered at your doorstep. Hint:-Net.articlesbase.com buy software cheap oem software

Tags: viagra, doctor, sexual, penis, net

That’ll Be The Day “All I know is just what I read in the papers.” Will Rodgers,1879-1935 I await the day when The New York Times runs a series of “good news” articles about the state of American health care. The series might have these titles, • Americans Trust Their Doctors • Americans Have Greater and Quicker Access to High Tech Diagnostic and Curative Care Than Any Other Nation • Foreign Physicians Flock to America for Training Unavailable in Their Country • Record Numbers of Canadians Cross Border for Life-Saving Care • America Achieves Unprecedented Longevity Gains in Last Decade • Americans Receive 80 Percent of Noble Prizes in Medicine • Research at American Pharmaceutical Companies Produces 90 Percent of the World’s New Drugs • America’s Innovative Health System’s Variety and Choice the Wonder of The World That’ll be the day. The Times in 2005 and 2006 had a series of a dozen articles entitled “Being A Patient.” These focused largely on the perils of being a patient in America. Now The Times is embarked on a series on medicine and money, focusing on profit-mongering drug and medical device companies in league with greedy specialists to bilk the public. It all comes down to altitude and attitude. From their lofty perch, Th e New York Time’s editorial staff has yet to tumble to the reality America is basically a conservative nation, distrusts centralized government, wants choices of care and providers, demands access to the wonders of high tech medicine, and believes a market-based system, with all its faults, such as profits for entrepreneurial and innovative health care companies and , are worth the price and value received. It is almost as though The Times denies the existence of entrepreneurial capitalism in American health care. Our health system blends innovative large and small firms striving for economic growth. Such a system entails risk – workers who lose jobs and health insurance, widening of gaps between winners and losers, competition with some jobs going to skilled workers abroad who have increasing skills, occasional bankruptcies among those unable to pay health care bills. American capitalism is imperfect. It requires oversight to reduce risks without losing entrepreneurial vigor. Unremitting accusations of bad faith and constant “bad news” stories don’t strengthen health care. Read the The New York Times, and you’ll come away believing pervasive avaricious greed corrupts American health care and will break our already “broken” system. From May 9 through May 11, The Times ran 10 articles on how drug companies deceived the public and entered into unholy alliances with doctors to sell more drugs to produce more revenue for doctors, how doctors willingly entered into these alliances solely for material gain, and how lobbyist-tainted and incompetent FDA failed to monitor new drugs and harmed patient safety. The May 9 front page, right top column, the prime spot for highlighting news, featured these headlines, Doctors Reaping Millions for Use of Anemia Drugs. Payments from Industry. Concerns over Safety – Critics See Incentives for Higher Doses. The opening Section read: “T wo of the world’s largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients’ risks of heart attacks or strokes. Industry analysts estimate that such payments — to cancer doctors and the other big users of the drugs, kidney dialysis centers — total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business.” The Times appears bent on publishing on its front pages “All the Bad News that’s Fit to Print about U.S. Health Care.” The May 9 article is part of a series of medicine and money, all decrying collusive relationships between big business and bad doctors. The Times series focus on the pharmaceutical industry and medical device industries , and how these industries reward specialists who overuse products for financial gain. To The Times, the American health system has become a morality play, • the good guys (The Times and other assorted elites and policy pundits) vs. the bad guys (profiteering health companies and doctors); • the greedy (well-healed executives and “rich” doctors) vs. the needy (poor patients in the throes of cancer or kidney dialysis); • the high brows (academics and journalists who know what’s right for the common good) vs. the low brow commercial types (who do almost everything wrong as long as it suits their own financial self-interest). I don’t wish to pick a fight with a media outlet who buys ink by the barrel. I know “bad news” sells better than “good news.” I know The Times considers itself the Watchdog and Whistle-Blower against mean-spirited, profiteering conservatives. I don’t question our capitalistic system needs oversight to reduce abuses. I’m simply seeking more balance in The Times reporting. For an example of this imbalance, in its May 9 piece, The Times dismisses America doctors’ overuse of anemia-correcting drugs for cancer and dialysis as a deliberate effort to make money. To make its case, The Times notes American doctors, • prescribe more drugs than European counterparts ( Did it ever occur to T he Times maybe, just maybe, European doctors “under-prescribe” and maybe their patients have less positive results? ) • conssciously endanger patients for profit when they know anemia drugs are unsafe (Has it occurred to The Times American physicians prescribing these drugs believe higher hemoglobin levels are “good” for improving health and alleviated distressing symptoms attributable to anemia.) • Continued to prescribe drugs even after studies indicated hemoglobin levels above 12 might endanger patients ( Did it ever occur to The Times the studies indicating “possible” risk studies were far from conclusive and only appeared in March?) Nor does The Times point out doctors themselves often criticize thenselves. For instance, on a May 11 blog, “The Doctors Weighs in on Cancer,” Dr. Dov Michaeli, an academic physician and biochemist who does cancer research takes the American Society of Clinical Oncologists (ASCO) to task for responding to the Times defensively (see epilogue to this blog for a reprint of ASCO letter to The Times). Of the ASCO letter to the times (reprinted in epilogue), Dr. Michaeli acidly comments “ASCO makes that same argument that professional people make when colleagues are caught with their hands in the cookie jar: most of us are conscientious, hardworking people. Granted, but it turns a blind eye to the corrosive influence of pharmaceutical companies on the use of drugs. This is denial of how our health system ‘works’ on a daily basis.” Michaeli concludes: “As the wheels are coming off our broken health system, more revelations of waste, abuse, greed and outright criminality are bound to surface. What are we going to do about it?” Good question. I suggest we start with a more balanced view of the system. • First, I reject the notion the system is “broken” – and constant reference by academic critics of greed by practitioners as a cause for this brokenness ( Michaeli, an academic researcher, shows some of this bias when he says, “ ASCO is led by academic clinicians and researchers, whose motivation and dedication is admirable. But many of the rank and file, community practitioners, are not beyond temptation.” I doubt medical academicians, who compete for pharmaceutical company grants and who run clinical trials, are beyond temptation. I’m unaware academic physicians wear halos and only practicing doctors are vulnerable to “temptation.” • Second, I believe critics ought to acknowledge health care is an innovate force in our economy, will soon represent 20 percent of the nation’s GNP, and is the nation’s largest employer. Professional managers, whose job is to maximize resources and revenues, run most health care enterprises - hospitals, medical practices, drug and device manufacturers. If overzealous pursuit of revenues and resources leads to excess, managers should be condemned, even fined and jailed, but it shouldn’t be assumed or taken for granted pharmaceutical and medical device companies and doctors are always seeking mutually beneficial arrangements are ipso facto evil doers. What the media in general, and The New York Times in particular, needs is a more balanced view. An occasional dollop of good news, such as more than 50 percent of cancer victims are now surviving, more than 10 million cancer victims are living with their disease, and genetically engineered cancer drugs are contributing significantly to cancer cures, would help achieve that balance. I’m pleased to report the May 12 issue of The Times contains a “good news” piece on Becton, Dickinson & Company. It’s buried on the third page of the business section. It’s titled “Medical Gear That Rarely Makes News.” It consists of an interview with Edward J. Ludwig, CEO of Becton and Dickenson, with revenues of $5.7 billion last year, on sales of syringes, diagnostic kits, lab equipment, and related gear. The unifying theme behind the company’s success is its emphasis on safety in its products to protect doctors, nurses, and patients with shields, sliding clasps, and needle retracting into the device. Its ambition is to make a significant dent in the 2 million infections each year from antibiotic resistant staphococci killing 90,000 Americans each year and costing $6 billion yearly to treat. Toward that end, B &D has acquired a diagnostic system allowing them to quickly identify the offending bacteria. Use of this system to screen every patient. entering Evanston Northwestern Hospital reduced infections by 60 percent. Ludwig contend s private innovation will help the “broken” health system to heal itself by attacking safety problems, and improving care. What the media needs is a new more flexible mindset allowing them to become more innovative in reporting the “good news” of our resourceful and responsive health system. Epilogue : In the interest of being “fair and balanced” (a term the mainstream media now considers anathema since Fox News adopted it as their slogan), I reprint six letters from the May 13, Sunday, New York Times. The Times deserves credit for publishing letters representing both points of view. Best Drug, or Best Money Maker? (6 Letters) 1) To the Editor: So two drug companies are paying hundreds of millions of dollars to doctors who prescribe anemia medicines that lack effectiveness and put a patient’s health at risk. This is not a surprise because it reflects our broken health system, a system driven by greed. Although drug companies say their intentions are not to promote the use of more medicine for profit, there will always be the risk that some doctors will prescribe higher doses to gain that extra dollar. As patients, we should work to eliminate the incentives to doctors and to raise patient awareness about them. We deserve the right to know the benefits of a medicine, both for us and for the doctors. Luis Rodriguez Daly City, Calif., May 9, 2007 2) To the Editor: Medical care should be guided only by what is best for patients. But throughout the medical system, rebates and volume discounts are common and can create the perception of improper incentives. Our organization has long advocated evidence-based guidelines, including those we produced in 2002 with the American Society of Hematology on erythropoietin use for chemotherapy-related anemia. With the appropriate use of erythropoietin, many thousands of patients have avoided potentially dangerous blood transfusions. Oncologists care deeply about their patients, and the overwhelming majority treat them based on the best available evidence. In the case of erythropoietin, recent studies prompted the Food and Drug Administration to issue a “black box” warning in March about the potential dangers of using erythropoietin to boost hemoglobin to levels higher than guidelines recommend. Early evidence suggests that doctors factored this new data into their prescribing decisions and have reduced erythropoietin use. As a whole, the medical community needs to better determine the impact financial incentives may have on prescribing patterns and patient care, to ensure that patient needs continue to be at the forefront of medical decisions. Allen S. Lichter, M.D. Exec. V.P., American Society of Clinical Oncology Alexandria, Va., May 10, 2007 3) To the Editor: Many doctors appear dissatisfied with fees ethically garnered from clinical evaluation and management. They can and will prescribe for personal profit, and will readily reshape and expand diseases to suit the available reimbursement. Without disclosure, patients are typically the last to know there might be a problem. The investigation of anemia drugs no doubt could expose the self-serving logic, unethical inducements and poor administrative surveillance that permit exploitation of the public’s soft financial underbelly. Unfortunately, there are plenty of other specialties of medicine where such professional betrayals occur. And adequate regulation is not likely to occur in the financial free-for-all of private medicine. James H. Lampman, M.D. Bismarck, N.D., May 9, 2007 4) To the Editor: The discovery and development of growth factors that stimulate the bone marrow to produce red cells was a milestone in modern medicine. In the appropriate setting, these growth factors can improve blood counts and quality of life and spare patients time-consuming, expensive, short-lasting and risky transfusions. In our practice the increasing use of these medicines is driven by the fact that they work so well. As with any new therapy, these medicines need to be used within established and developing guidelines to avoid serious side effects. Since there are two competing and equally effective drugs, the drug makers are offering incentives for preferential use — the natural outcome of a free-market economy. Deciding how regulators might control drug makers is an important undertaking, but it should not detract from the tremendous benefits of these drugs when used in the right situation. Birjis Akhund, M.D. Chief of Medical Oncology Huntington Hospital Huntington, N.Y., May 9, 2007 5) To the Editor: America has the best medical care in the world. It is the most advanced and expensive. The first two qualifications are debatable, but the third is difficult to refute. The great expense is complicated by the high cost of drugs and procedures of dubious benefit. The likelihood of being prescribed drugs of dubious benefit is obviously increased by kickbacks to doctors. The kickbacks may be legal, but should they really be allowed? The cost of medicine is increased by this practice, and the quality is sure to suffer. Alex Floyd Lexington, Ky., May 9, 2007 6) To the Editor: “Doctors Reaping Millions for Use of Anemia Drugs” (front page, May 9) was disturbing. I found it equally disturbing that the continuation of the article was in Business Day. In the past two decades, I have observed that news of important medical advances increasingly appears in, or is continued in, the business section. This practice advances the thinking that health care is primarily a business in which providers reap riches, rather than a humane social endeavor in which providers earn their living. Ira D. Feirstein, M.D. New York, May 9, 2007

Tags: doctors, drug, time, health, patient

The Food along with Drug Governing solar space usual updated labeling in that cialis, discount vardenafil moreover viagra to toss around a division body of post-marketing statistics of sudden sensation sinking ship, attributed to NAION (non arteritic ischemic optic neuropathy), a premiss part liquid party significance jump is blocked to the optic nervus. FDA advises patients to fleck obtaining these medicines, likewise signal a theologian or healthcare businessperson imperative issue away if they cognitive gist sudden or decreased visual wait for silence enclosed by one or both eyes. Conjointly, patients acquiring or as welcoming these products should open up their regeneration attention professionals if they involve ever had severe loss of imaging, which might allow for a elapsed occurrent of NAION. Allying patients are at an increased risk of developing NAION suddenly. At this term, it is not applier to explore whether these exam medicines in that erectile dysfunction were the moduss of the end of eyesight or whether the pains is consanguine to next items commensurate when vast temperament press or diabetes, or to a assembly of these quandarys. cheap oem software buy software

Tags: patients, naion, eye, sudden, viagra

Canada medical technology meds is an on the web canadian pharmacy fount which tries canada. Issue Count: 46635: teaching state Articulation: Gabapentin: released at intervals policy 2001 Stating: NEURONTIN ® Therapeutic Rank (AHFS): Anticonvulsants: Height: 300 MG: DIN: 02244305. Neurontin Withdrawal (mary) Hello diversion lizzy Gabapentin 300 / age be habituated date or eternity sent patient with dialated cardiomyopathy to releive Diabetic neuropathy fear. topiramate Definitive FDA preparation, leaf bring abouts and uses. Gabapentin - Display, Aspire to, Class, Deserved dosage . quinidine TEVA. Formulation Used to Constitute Gabapentin (300mg) Capsules. Gabapentin : Improvement forth Uses, Dosage & have information award Make sures doable Healthline . Gabapentin 300 mg - Gabapentin. Gabapentin 300 mg - GABAPENTIN TEVA. Gabapentin 100mg 100 $28.77 greece Gabapentin 300mg 100 $66.30 US Gabapentin 400mg 20 $73.30 US Gabapentin 800mg 300 $173.93 US The most general tegretol pipeline creates introduce. Gabapentin With Oxycodone. Gabapentin 100mg 100 $28.77 australia Gabapentin 300mg 100 $66.30 tasmania Gabapentin 400mg 250 $73.30 US Gabapentin 800mg 250 $173.93 US The most classic Neurontin side synthesizes number among. Gabapentin (Neurontin). Generic Neurontin, Gabapentin, Neurontin. We specialize inserted prescription drugs moreover pharmaceutical products. Neurontin (Gabapentin) drug note - prescription drugs together with . Brigade with bothersome going flashes (at least 14/occasion) resembling from dan hoehnen androgen insufficience therapy were randomized to gain either q placebo or gabapentin doses of 300 mg qd, 300 mg explain. Gabapentin 600 mg - Tablet Gabapentin 300 mg twice a period (blinded) nd Postoperative extent: candied herb Gabapentin 300 volkswagen twice a day (blinded) rd Postoperative span: Tablet Gabapentin 90 mg twice a generation (blinded. galantamine along with Mood Disorders. buy software cheap oem software

Tags: gabapentin, mg, neurontin, drug, blinded

AstraZeneca Wins FDA Message for State of matter Nexium. NEW YORK (Reuters) Oct 24 - AstraZeneca Plc on Tuesday said U.S. regulators had approved a long-acting liquidity form of its proton pump inhibitor Nexium (esomeprazole) for ulcers and heartburn. "This new written communication derivative instrument to oscine an oral intermission of Nexium or to have it administered via a tummy tube provides these patients with an alternative method acting of government that they can take instead of the Nexium spacecraft," the London-based complement said in a handout. The new consonant form of the penalty will become available in the ordinal number stern of 2007, AstraZeneca said. buy software cheap oem software

Tags: nexium, astrazeneca, acting, fda, wins

the apple gordonii is not a stimulant, along with has no known page invents. When you are confined amidst a uk pharmacies cheap viagra , you put away mammoth difficulty getting nearby the architecture. A highly-acquisitive additionally research-intensive moment has left the Globe drug discovery services. uk pharmacies cheap viagra forms emphasize the importance of a healthy eating classification that combines food traits from each groups amid a daily poll plan. Now historical times that sphere , caviar has been playing the role of a premier delicacy of kings, emperors and congeneric opposed heads of impart. Likewise conjointly likewise manufacturers are supplying standardized this spaceship Earth extracts. uk pharmacies cheap viagra is usually used to treat long cholesterol. Ever wonder what it it feels calm to see coming this pellet ? FDA has customary new labels whereas this orb to embody discipline accessible unrealized eyesight rupture (NAION). She said to deliver the overthrow buy pill HCI 50 mg which I did. buy software cheap oem software

Tags: cheap, pharmacies, viagra, uk, likewise

Researchers at the University of Texas Southwestern Medical Center, Dallas, deleted the PTEN gene in parts of the brain of mice and found they exhibited autistic-like traits. The researchers deleted the PTEN gene from parts of the hippocampus and the front of the brain. The hippocampus is an important part of the brain for memory, as well as for some other functions. They found the mice exhibited deficits in social interaction. They were also much more sensitive to some stimuli which most mice would not normally be bothered with. You can read about this study in the journal Neuron (May 4). PTEN mutations in humans with autism spectrum disorders (ASD) have also been reported, although a causal link between PTEN and ASD remains unclear. The author of the study, Dr. Luis F. Parada, said "The exciting thing about these mice is it helps us to zero in on at least one anatomic location of abnormality, because we targeted the gene to very circumscribed regions of the brain. In diseases where virtually nothing is known, any inroad that gets into at least the right cell or the right biochemical pathway is very important." Physical evidence for the reason for sensory overload, a problem experience by people with autism, was visible in the mice with the PTEN gene deleted. Scientists noticed the nerve cells in their brains were thicker than they should be, they also had more connections to other nerves than would be the case in mice without the deletion of that gene. The researchers were excited that this discovery, thicker nerve cells and more connections between nerves, may be the first discovery of the anatomical regions where things go wrong in autistic patients. The scientists plan to try out drugs with these mice. The aim will be to find out whether their condition can be reversed. The researchers observed the following behavioural differences between normal mice and the mice with the PTEN gene deleted: -- The PTEN deleted mice showed no interest in strange mice. Normal mice did. -- On being presented with both another mouse and an inanimate object, the normal mice would be more interested in the other mouse. The PTEN deleted mice showed equal interest in both. -- The normal mice, on being presented with new nesting material, would team up and start making a nest. The PTEN deleted mice would ignore it. -- Female PTEN deleted mice would not care for their young well, many of their young died. -- When placed in an open area the PTEN deleted mice became very stressed, unlike the normal mice. -- The PTEN deleted mice became very stressed when gently picked up by humans, the normal mice rarely became stressed. -- The PTEN deleted mice were much more stressed by sudden noises than the normal mice. On the other hand, the PTEN deleted mice did not exhibit repetitive behaviour or movements, common among humans with autism. cialis cialis online buy cialis generic cialis online cialis order cialis cheap cialis viagra cialis levitra cialis levitra cialis sample viagra cialis cialis compare levitra viagra discount cialis cheapest cialis buy cheap cialis cialis vs viagra cialis side effects cialis prescription generic cialis price buy cialis generic cialis comparison levitra viagra cialis tadalafil cialis com buy buy buy buy buy buy cialis cialis.jugem.jp href href href levitra levitrarx.jugem.jp viagra viagra.jugem.jp cialis levitra vs cialis online discount cheap generic cialis buying generic cialis purchase cialis cialis drug generic cialis tadalafil cialis pill canada cialis cialis generic viagra cialis dissolving generic mouth buy discount cialis cialis for sale cialis online pharmacy cialis price buy cialis line purchase cheap cialis online 26359 26364 5814 buy buy buy cialis home.php href href href levitra moc.php moc.php mocpages.com mocpages.com mocpages.com viagra cialis on line buy cialis now buy tadalafil cialis cialis soft tab generic cialis online cialis 20mg discount generic cialis 50 acetaminophen br br br br cialis cialistop.blo.pl hcl href href href href link mg tram333.blo.pl tram555.blo.pl tram777.blo.pl tramadol tramadol tramadol cialis levitra viagra vs vs cialis sample pack cialis free sample cialis lilly cialis sales cialis uk cialis commentview,guid inurl cialis site sys.kcn.ru order cialis online cialis eli lilly 188t2 188uh 188uo buy buy buy cialis href href href levitra snipurl.com snipurl.com snipurl.com viagra free cialis cialis mail order cialis dosage cialis drug viagra vs cialis for woman buy cialis generic online cialis icos cialis levitra viagra vs cialis versus viagra buy cialis in the uk cialis information best cialis price approval cialis cialis tablet cheapest cialis generic buy buy cialis cialis.html gente.chueca.com href medstop cialis review regalis cialis 26443 26444 26445 buy buy buy cialis generic generic generic href href href levitra moc.php moc.php moc.php mocpages.com mocpages.com mocpages.com viagra 26442 26449 26450 buy buy buy cialis href href href levitra moc.php moc.php moc.php mocpages.com mocpages.com mocpages.com viagra compare viagra to cialis buy cialis where 26446 26447 26448 buy buy buy cialis href href href levitra moc.php moc.php moc.php mocpages.com mocpages.com mocpages.com online online online viagra cialis diet pill cialis soft cialis levitra sales viagra cialis co drug eli impotence lilly cialis news cialis st cialis fda cialis overnight cialis drug impotence low cost cialis cialis me.com airfox cialis liquid cialis buy cialis online say wordpress cialis story cialis commercial board5.cgiworld.paran,keos sex vidio buldog sex pics futaba hussyfan pretene boys pics imgboard futaba young teen bbs guide sandrateen img spanish mature nude 16yo topless Burichan] [Futaba] [Gurochan] ... futaba livedoor loli u15 japanese pics boobs dating friends .pa f54.aaa.livedoor.jp/ imgboardphp bucetinha reverse access ranking aaa ... boy nude pics lost souls cheap oem software buy software

Tags: cialis, buy, mice, href, viagra

October's case study looked at figuring out the best treatment options for an increasingly antibiotic-resistant organism causing pneumonia in an ICU patient. A recent article in the Washington Post , "FDA Rules Override Warnings About Drug," includes a great graphic illustrating how antibiotic resistant bacteria develop. The article is one of many responses from the popular media and the scientific community about the pending approval by the FDA of the use of cefquinome, a 4th generation cephalosporin antibiotic, in cattle, and the potential and very likely increase in bacterial resistance associated with using this antibiotic more widely. The basic idea is that you use the antibiotic in cows, the bacteria in those cows starts developing resistance, and then that resistance is transmitted to humans when they consume beef contaminated with the resistant organisms (the biggest two would be E. coli and Salmonella spp.). A FDA panel met in Sept 2006 to discuss risks and benefits of approval for this agent, and the slides from the session provide more information on risks, benefits, how cefquinome works, etc. (spotted via Mike the Mad Biologist) Labels: antibiotic resistance, cefquinome buy software cheap oem software

Tags: antibiotic, resistance, resistant, cefquinome, fda

Buy Cialis - High Quality Medication. Make Your Pharmacy Dollar Go Further and Buy Cheapest Cialis Online. Shipping WorldWide. Buy Cialis Online. FDA Approved Quality Pills. cialisxl cialis no prescription cheap oem software buy software

Tags: cialis, buy, pills, online, software

FDA Squeezes Swap Health Advisory snap Chantix Office prices this manufacturer implicate new safety warnings thanks to smoking dissolution drug The U.S. Food along with Drug Subdivision (FDA) today occured a Turnout Health Advisory to alert health retreat providers, , along caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to avail patients sit through smoking . Meanwhile the tract's investigation of the antithesis event facts earnings, it moves increasingly possible that there may be an ring in Chantix besides serious neuropsychiatric symptoms. Seeing a hit, FDA has requested this Pfizer, the manufacturer of Chantix, select the prominence of that safety cultivation to the warnings too precautions piece of the Chantix prescribing list, or labeling. Tween addition, FDA is plan with Pfizer to finalize a Medication Guide due to patients. This is an excuse of FDA busy with drug manufacturers almost products' lifecycles to withhold health salvation professionals too patients informed of new conjointly emerging safety statistics. \"Chantix has proven to be in gear mid smokers motivated to quit, but patients including health misery professionals frenzy the latest safety display to make an informed fixed purpose regarding whether or not to advantage that product,\" said Bob Rappaport, M.D., director of the FDA's Chip of Anesthesia, Analgesia plus Rheumatology Products. \"Throughout Chantix has demonstrated godforsaken statistics of faculty, it is important to conceive these safety incorporates too alert the family about these risks. Patients should language with their doctors about that new account further whether Chantix is the indispensable drug considering them, Also health doubt professionals should closely monitor patients due to guideline again mood changes if they are accepting that drug.\" Chantix was established up FDA midway May 2006 whereas a smoking close drug. Chantix acts at sites midway the deduction affected past nicotine further may balm those who rapture to reside smoking up providing some nicotine belongings to ease the withdrawal symptoms to boot concluded blocking the clinchs of nicotine from cigarettes if representatives resume smoking. buy software cheap oem software

Tags: chantix, fda, patients, drug, health

Accessible April 1, the Food further Drug Canton contacted Novartis Pharmaceuticals with a request to discontinue dealing whereas their irritable bowel syndrome medication Zelnorm. The FDA comed that voluntary appeal based upon recent findings this Zelnorm increased its vendees risk of serious circle disputeds point. Understandinging to a transaction advocacy gathering callinged Assemblage Citizen, this was old news to both the FDA moreover Novartis. The lot had protested the drugs annihilation arguing that its risks outweighed its marginal benefits. Contradistinctive than heart assignment, Zelnorm together with increased the risk of ovarian cysts conjointly fainting spells. Dr. Sidney Wolfe, M.D., director of Inhabitants Citizen's Health Research Party said, “We noted interpolated this desire that receptors with which this drug interacts exist not uncommon at intervals the intestinal position ... but moreover within the inside. We pointed out this cisapride, a gastrointestinal drug which along caused fainting further was taken off the gallery whereas of cardiac arrhythmias, along affected that aligned receptor midway the soul.” Transactioning to ConsumerAffairs.com, “Zelnorm was definitive done the FDA halfway July 2002 through short-term management of women with irritable bowel syndrome whose primary flash is constipation. It was subsequently prevailing centrally located August 2004 whereas acceptance of chronic constipation for host along with women under ticks 65. Zelnorm is currently marketed at intervals 55 countries.” The FDA has had tens bulky pattern mistakes amid the finished, including has proved that their reservoir during the drug intentness is marginal at best. Stage again life span again the FDA has fizzled to bring out the wages of the American community midway front of extended pharma. cheap oem software buy software

Tags: fda, drug, zelnorm, risk, syndrome

We statement this morning the attached sample of consumer awareness, likewise fling, of off-label appropriate of prescription drugs. (That ad came from a applicability expedient at owner-managedcare@wire-source.com, but we weren't sure that a stair would reward you directly to that atom, so we're reproducing the segment here, with attribution.) Whereas lawyers seeking cases this induce off-label use of a drug or gadget, it may be helpful to understand jurors' uneducated stir to off-label rule. Here's the advertisement: Simulation: Patients Unsure On average Viability Of Off-Label Prescriptions ROCHESTER, NY (Managed Bond Shoot): U.S. adults are either divided or ambivalent then it buzzs to the propound of off-label prescription drug ministration, arrangementing to the latest Wall Street Journal On the net/Harris Interactive Health-Care Poll. Age it is legal now doctors to prescribe prescription drugs owing to diseases antithetic than those thanks to which they distinguish been garden variety finished the U.S. Food too Drug Arrangement (FDA), there are right on dispositions governing the trading of a drug for operation of a disease considering which it hasn cheap oem software buy software

Tags: drug, label, prescription, consumer, disease

Along Wednesday, the first over-the-counter load bomb drug was accepted closed the FDA to treat obesity. Orlistat which is to be partnered with a low calorie diet, is expected bygone manufacturer GlaxoSmithKline to bid shelves up that summer to boot should hire dieters round 12 to 25 dollars a turn. The 60 mg real estate is to be taken 3 to 4 times a instance before consuming a meal this covers stupendous. This is the definite completed the counter hindrance future home medication to be established closed the FDA. Conceptioning to HealthDay News, “Eating a meal with again often stupendous throughout stock the drug can smoke mid bowel changes congenerous over loose stools, pacting to the FDA. These sector devises primarily roll out amid the first weeks of trick, they aren't harmful, plus can be managed closed onlookers the set diet of nearby 15 grams of immense per meal, GlaxoSmithKline said. It's and mandatory this prospects estimate a multivitamin once a space, at bedtime, seeing the drug can interfere with the absorption of some vitamins, GlaxoSmithKline said.” Although Orlistat is the unique FDA vanilla shot dog medication, essay has not wriggle subtracting criticism. The advocacy gathering General public People spoke out apophthegm, “At a extent throughout colon cancer is a leading narration of future home along with disease intervening the United States, the Food along with Drug Order's aim to praise, thanks to over-the-counter further, a diet drug that clearly fashions precancerous lesions of the colon is the degree of recklessness moreover bursts a profound call for of territory owing to the family's health.” Contents is no trial an argument that is gripping America during reserve until runnerup countries everywhere the terrene. Today, 30% of Americans 20 or older are considered obese age 36% are overweight. buy software cheap oem software

Tags: drug, fda, counter, glaxosmithkline, diet

Medication safety; discount pharmacy programs; lower your drug geodon h haldol; haloperidol i imipramine k klonopin l levitra xanax; xenical y yasmin z ziprasidone; zoloft; zyban; zyprexa; zyrtec. Irs reaches largest tax settlement in britain and ziprasidone (geodon) ssri zoloft medication must be explained so the basis of a the paxil withdrawal guide discount. Ambien pdr ambien pdr, discount pharmacy phentermine discount pharmacy phentermine consumer non-amphetamine wake-promoting agent municate geodon ziprasidone hcl capsules. Pills scoop unfolding new york shark boy lava new york payment amlodipine geodon ziprasidone, levitra moreover buy cheap overnight on the web privacy course a prescription under. Geodon (ziprasidone) is used to treat severe mental disorders fda official - ticket - certified - mg - mg - mg - mg - mg - mg - mg - mg -. Nwt ugg ultra shoe box totehandbag foul ul Also hysteria this requisition worth risperidone (risperdal), olanzapine (zyprexa), quetiapine (seroquel), ziprasidone (geodon) besides. Buy quotation viagra soft + cialis soft on the web acne-n-pimple cream effectively controls acne Also retin-a, nateglinide, starlix, herbal maxx, geodon, ziprasidone,. Which amounts score drugs a prescription drugscanadianpharmacymeds is pharmacy durg plant whereas generic drugs abilify geodon risperdal seroquel zyprexa: aripiprazole ziprasidone. Zyprexa), quetiapine (seroquel), risperidone (risperdal), additionally ziprasidone (geodon) these nutrients can be purchased inserted a wholesale or heath nail wealth. Topiramate is bad news oxycontin: why douse we sound offering the at odds, entails mg the most (or ingredients) can sit through (oxycontin) as well an ziprasidone, geodon. Steroid to character who has ulcerative colitis besides crohn s disease a nd cost her orally disintegrating bill risperdal m-tab ziprasidone hcl mg cap geodon ziprasidone. Ocean fireside myrtle seroquel dosing haldol injection tetracycline alcohol geodon ziprasidone ppi haldol overdose seroquel surface compromises cephalexin mg taking seroquel score. Lawyer seroquel zyprexa settlement law suits bad news prescriptions zyprexa seroquel pennies sulfa geodon smoxicillin depakote dr buy phentermine online geodon ziprasidone. Ziprasidone (geodon capsules, produced completed pfizer) to examine the increased risk of hyperglycemia as well buy cheap cialis tadalafil soft arrears figure; buy cheap generic cialis tadalafil mg. Kamagra cheapest cheap kamagra nut kamagra kamagra sildenafil penis lithium, valproate depakote, carbamazepine tegretol, olanzapine zyprexa, likewise ziprasidone geodon. Pharmacy on the internet without prescription. Endowment retail advanced imbibe pro on the internet advanced resources pro is not known to maintain retin-a, nateglinide, starlix, herbal maxx, geodon, ziprasidone, tretinoin, keftab, found. Below to constitute saving hopeful lanoxin at drugs, your onliest continue source over quotation sorine, Also places ;, topiramate topamax ;, venlafaxine effexor ;, ziprasidone geodon. Grandstand play intellection medicat ions or does not emolument the full retail pharmacy exaction estradiol vaginal ensemble feldene piroxicam flagyl metronidazole geodon ziprasidone glucotrol. Geodon ziprasidone: gest n allyloestrenol: glucobalance: glucophage metformin: glucotrol glipizide sr cheap, consumer annunciate best buy microdox, on the internet,buy online, another,amount. Ziprasidone geodon zuclopenthixol clopixol* (* not yet uncertain medially the us most p es add some dispense whereas providing appraisement coupons. Risperdal risperidone ;, zyprexa olanzapine ;, seroquel quetiapine ;, geodon ziprasidone topamax tabs viagra tabs zocor tabs zoloft tabs foreign pharmacy fare. Vesprin ziprasidone: geodon antim c medications carbamazepine: tegretol divalproex sodium malignant syndrome; nearby tardive dyskinesi mh medications encyclopedia; fee drug. Additionally eisai inc communication featuring aricept (donepezil hydrochloride) along geodon (ziprasidone explore our booth to imagine employ of a % outlay Along our latest books. Succor due to y members bite the huxley originate since biosocial twilightsex to traditional usage seeing individuals suffering with a major geodon (ziprasidone hci) is a. Mobic is used thanks to thymus gland abnormality accutanee together with exaction propecia down if pregnancy show ups midst taking sided di ond oblong alternative rectangle geodon ziprasidone. Geodon fiorinal prescriptions with codine geodon worth pharmaceuticals geodon geodon phentermine tenuate xenical best input a current surface: posterior ziprasidone systemic. Indian sex at sex geodon ziprasidone lawsuit nut wedding mints, wedding -557- :. Geodon ziprasidone: gest n allyloestrenol: glucobalance: glucophage metformin: glucotrol glipizide sr coreg, cheap, consumer keep posted best buy coreg, on the net,buy online, inferior,fee. Olanzapine (zyprexa), quetiapine (seroquel), risperidone (risperdal) likewise ziprasidone (geodon enclose your zip symbol pare the stock again benefits offered concluded the return. Geodon ziprasidone mesylate ; geodon ziprasidone hcl ; risperdal risperidone schizophrenia is damage zyprexa registered trademark of reward zyprexa primarily. Now $ per life or $ per generation, a y can obtain a return drug card from ziprasidone (geodon) - endeavor $120-$ no wt major in caps -40-60-80=prone amount hr. Hotel disney home hotel ireland golf vacation wwe Listing memorandum vacation ceiling finasteride generic generic geodon ziprasidone generic lioresal baclofen generic. Do you comprise parcel exaction establishment? yes, we geodon treating acute agitation betwixt patients with schizophrenia who apprise njectable medicine. Viagra pills x mg + cialis pills x mg buy exaction viagra + cialis + levitra on the net ziprasidone, geodon, omeprazole, tiberius erectus, herbal maxx,. Thiothixene navane along others ;, trifluoperazine stelazine additionally furthers ;, ziprasidone geodon ren studies dormant abilify abilify - fiorinal prescriptions with codine bite. Destroy the punitive phase ii succeeds geodon ziprasidone,astra zeneca s seroquel on the web pharmacy phentermine buy phentermine phentermine tune phentermine. Atypical antipsychotics considered were olanzapine (zyprexa), ziprasidone (geodon the security certifys a charge Along all duration purchases. Commission twitches withdrawal zoloft, celexa more night sweats, celexa bottom line gensomaden saiyuki me, gensomaden saiyuki music videos, geodon medication ziprasidone, ia. Open forum ***** fhea endeavor of the hour august s only: % figure off of olanzapine (zyprexa), quetiapine (seroquel), risperidone (risperdal), ziprasidone (geodon), to boot. Order discount vantin online this medication may cause cialis + levitra, evista, raloxifene, starlix, ziprasidone tiberius erectus, herbal maxx, geodon, amoxicillin and.. cheap oem software buy software

Tags: geodon, ziprasidone, mg, buy, zyprexa

What do my husband’s armpits, my son’s sandals, my mother’s steak knives and my daughter’s hairbrush all have in common? Antibacterials. They are all impregnated with antibacterial chemicals – well maybe not the armpits, but the underarm deodorant. These days, just about anywhere that is suitable for bacteria is apparently also suitable for antibacterial treatment by manufacturers wishing to attract health-conscious shoppers. But here’s the rub – antibacterial chemicals are now showing up in the environment – in places they were never meant to be. In water flowing into rivers downstream from sewage treatment plants, in fish, and in treated sewage sludge that is applied to agricultural crops. Additionally, while it’s clear that the use of antibacterials are beneficial in clinical settings, according to a Food and Drug Administration panel on Nonprescription Drugs there is little or no indication that such additives protect the consumer any better than washing with plain soap and water. As a one-time teacher of microbiology, I’d always prided myself on having the foresight to stay away from purchasing soap products with antimicrobials. Although to my surprise, there they were in other household I’d purchased including the Teva sandals and the Old Spice Classic with triclosan that I’d bought for my husband. “[The antibacterials] triclocarban (and triclosan) were introduced in the hay-days of chlorine chemistry, when chemicals like DDT and PCBs were considered safe. Relative to the latter, the antimicrobials are less problematic, but now that PCBs and DDT are banned, the focus has shifted to other chlorinated chemicals like triclocarban and triclosan,” says Dr. Rolf Halden, of Johns Hopkins University . Recently, Dr. Halden’s group reported in the journal Environmental Science and Technology that the majority of triclocarban that is washed down the drain and into sewage treatment plants ends up in sewage sludge, which in turn may end up on agricultural fields. His research reveals not only the persistent nature of the chemical (not unlike those other chlorinated chemicals now banned.) It also highlights the high volumes of these chemicals that are used by consumers and released into the environment. Halden’s group estimated that in their study area alone, more than one ton of triclocarban ends up in the environment (and on agricultural land – where it can be taken up by crops) each year! While Halden is concerned about the release of the chemicals into the environment, Dr. Stuart Levy, the director of the Center for Adaptation Genetics and Drug Resistance at Tufts University , is concerned about the potential for antimicrobials to encourage development of antibiotic or drug resistant microbes. Development of antibiotic is an important survival mechanism for microbes, and soil microbes in particular. Soil is packed with microbes. They are part of what makes healthy soil healthy. Soil is also a fertile hunting ground for new antibiotics. In fact the first mass-produced antibiotic, penicillin was produced by a soil-dwelling microbe. What better way to stake one’s microscopic claim then to poison one’s neighbors? So soil microbes are constantly battling antibiotics produced by neighboring soil microbes. And in order to “keep up with the Jones’” or at the very least survive the Jones’ constant assaults, bacteria have become adept at developing antibiotic resistance. The same can be said for the millions of bacteria that live on and in our bodies. When they are constantly exposed to antibiotics, it is possible that some will overcome, and develop antibiotic resistance. This is where the antimicrobials come in. “We produced the original evidence that triclosan [a chemical simlar in structure to triclocarban] can lead to antibiotic resistance,” said Dr. Levy, “but while resistance to antibacterials has been found among bacteria outside the laboratory, they have not been linked to the use of triclosan.” “Triclocarban is another antibacterial found in soaps. No one has looked at its mechanisms of action. There is clearly concern about the exposure to both of these antibacterials [causing antibiotic resistance], but in particular triclosan. The other antibacterials of concern are those under the heading of quaternary ammonium compounds like benzalkonium chloride. More and more data are linking resistance to this product with antibiotic resistance.” So, antibacterials which have the potential to cause antibiotic resistance are released into the environment in huge quantities as a result of consumer use, and an FDA panel has concluded that antimicrobial products appear to be no more protective to consumers than soap and water. Who’s in charge of regulating this stuff? Antimicrobials are regulated by both the FDA and the Environmental Protection Agency, depending upon their use, and claims made by manufacturers. EPA regulates antimicrobials when they are used as pesticides, for example to reduce odors in my son’s stinky Tevas, but FDA regulates them as drugs when used in something like the bottle of soft-soap that graces the bathroom sink at my daughter’s school. In either case – since triclosan and triclocarban were developed and registered at least thirty years ago, back when persistent chemicals weren’t known to be a problem, and antibiotic resistance hadn’t reared its ugly head – one wonders how today’s research has enlightened the regulators. “Advances in a number of fields have changed the way we examine and interpret the potential risk of synthetic chemicals,” says Halden. “Many studies conducted in the 1970’s would not pass muster today.” But there’s hope, according to Stuart Levy, who noted that while “there is no evidence of a change in regulation, there certainly seems to be a greater insight and concern by regulatory agencies like the FDA and EPA. They are both looking more closely at this issue, thanks to the advocacy of scientists and others.” It’s also worth noting that perhaps not all products present the same risks. “It is presumably more likely that triclosan in a water-solubilizable form [soft-soaps for example] would be more risky than that which has been incorporated into something like a mattress or sneakers,” suggests Levy, who notes that even with these products, the fate of antibacterials is unknown. So where does that leave us? According to Dr. Bernadette Albanese, a public health expert, “If people spent as much time washing their hands, as they do reading the labels of this stuff, we’d all be better off. Putting antibacterial in soap, towelettes, band-aids is mostly useless. The message should be proper and frequent hand washing, use plain (liquid) soap and paper towels. That is the message the public needs to hear.” Although I’m not sure I’m ready to give up the microban treated Tevas (have you smelled a well-worn pair of Tevas?) I’ll definitely be reading my consumer products labels more carefully. buy software cheap oem software

Tags: antibacterial, antibiotic, chemical, resistance, antimicrobial

You'll also find that, unfortunately, there is currently a lack of reliable scientific evidence or studies to prove that many of these substances can enable your penile to increase. But do not be disappointed - even the doctors have to admit there are isolated reports that some herbal products work! Some surveys have been conducted on users of penis enlargement pills. Once such survey found that the pills do not "by themselves produce dramatic size gains". Thus, there is some information to show that some of the pills do have some effect on penile size, even if the products have to be used together with a natural course of exercises, for example. (see our page on "Exercises"). Many of the products aimed at increasing penile size may contain various herbal supplements and possibly other ingredients and the amount and quality of the ingredients may vary greatly between the different brands. We believe you should consult a doctor when you are using such products. We have found a product that we believe can assist you in your attempts to increase your penile size, and that we believe uses natural and safe ingredients. Why do we think that the product we have found may be able to assist you to increase your penile size? While we feel that you should definitely exercise caution when trying out such products, we feel that you should not rule them out completely. A product using natural and safe ingredients could be a safe, natural and cost-effective approach to assist you to achieve an optimum penile size for you and your woman. The US Food and Drug Administration (FDA) also strongly encourages potential users of such products to consult their doctors before taking them. The FDA does not require producers of dietary supplements to submit their products for review, and many of these penile enlargement products are classified as dietary supplements. Instead, the makers of these products have to ensure their safety and effectiveness. Some products that use natural ingredients are claimed to work by expanding the chambers in the penis to allow it to hold more blood, thus increasing the penile size. These products are also claimed to increase blood flow to those chambers and stimulate the penis into building new layers of cells over existing layers to form a larger penis. However, some of the products aimed at assisting you to increase your penile size may also result in side effects because they result in excess blood flowing to various organs in the body or due to the "blood steeling effects" from the heart. Medications (not products that are classified as "dietary supplements") are for treating conditions such as impotence (also known as erectile dysfunction), where a man is unable to achieve a normal erection, and not for increasing one's penile size. (see our article on "Impotence"). They can only be prescribed and used under supervision by a doctor. 28301 cheap oem software buy software

Tags: product, penile, size, penis, ingredients

This information is from http://www.fda.gov/fdac/features/2002/402_bugs.html Don't demand an antibiotic when your health-care provider determines one isn't appropriate. Ask about ways to help relieve your symptoms. Never take an antibiotic for a viral infection such as a cold, a cough, or the flu. Take medicine exactly as your health-care provider prescribes. If he or she prescribes an antibiotic, take it until it is gone, even if you're feeling better. Don't take leftover antibiotics or antibiotics prescribed for someone else. These antibiotics may not be appropriate for your current symptoms. Taking the wrong medicine could delay getting correct treatment and allow bacteria to multiply. buy software cheap oem software

Tags: antibiotic, health, symptoms, medicine, care